Drupal.behaviors.print = function(context) {window.print();window.close();}>
New Weill Cornell Precision Medicine Institute Plans to Offer Genomically Guided Treatment after CLIA Approval
February 06, 2013
New Weill Cornell Precision Medicine Institute Plans to Offer Genomically Guided Treatment after CLIA Approval
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Weill Cornell Precision Medicine Institute Awaiting CLIA Approval; Will Use Sequencing To Guide Cancer Care
February 6, 2013 / Clinical Sequencing News
Uppsala Team's ProteinSeq Assay Combines PLA and Next-Gen Sequencing for Protein Detection
October 7, 2011 / ProteoMonitor
Alacris Attains Illumina CSPro Certification for NGS
June 11, 2013 / GenomeWeb Daily News
Ongoing French Study Explores Benefits of NGS, aCGH Screening to Guide Enrollment in Phase I Trials for Advanced Cancer Patients
June 5, 2013 / Clinical Sequencing News
Institute for Cancer Research, Royal Marsden Program to Expand Cancer Predisposition Testing
May 29, 2013 / Clinical Sequencing News